| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 463 / 669 | 30th | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
AFMN Biomedicine
AFMN Biomedicine is Scopus-indexed (Q3, CiteScore 0.6), WoS ESCI. Published by University of Nis, Faculty of Medicine.
Checked against the index lists dated .
ISSN 3104-3127Verify ISSN ↗3104-3135Verify ISSN ↗
Publisher: University of Nis, Faculty of Medicine
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is AFMN Biomedicine indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2025–present, best quartile Q3, CiteScore 0.6.
What quartile is AFMN Biomedicine in Scopus?
AFMN Biomedicine is Q3 in Medicine (all) (rank 463 of 669), by CiteScore 2025.
What is the impact factor of AFMN Biomedicine?
AFMN Biomedicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.6, which places it in quartile Q3 at the 30th percentile of its subject.
Who publishes AFMN Biomedicine and what is its ISSN?
AFMN Biomedicine is published by University of Nis, Faculty of Medicine. Its print ISSN is 3104-3127 and its online ISSN is 3104-3135.
Is AFMN Biomedicine in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is AFMN Biomedicine open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is AFMN Biomedicine? — open metrics via OpenAlex
AFMN Biomedicine has an h-index of 16 and a 2-year mean of 0.12 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q3. On 2-year citations it ranks #508 of 646 Scopus journals in Medicine (all).
AFMN Biomedicine published 32 papers in 2025; its busiest recent year was 2023 with 55. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in AFMN Biomedicine? — latest 95 articles, 2023–2026
In its latest 95 research articles (2023–2026), authors are most often from Serbia (60.5%), Iran (6.3%) and Iraq (5.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for AFMN Biomedicine? — indicators, not proof of misconduct
Scopus status: Active. 4 retracted papers are recorded (6.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 4 · 6.8 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration60.5% of recent authorship from Serbia
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.